|
|
Xin-Ming Shen, Taku Fukuda, Kinji Ohno, Steven M. Sine, Andrew G. Engel
J Clin Invest. 2008;
118(5):1867
doi:10.1172/JCI34527
Abstract |
Full text
| PDF

C
ongenital myasthenias (CMs) arise from defects in neuromuscular junction–associated proteins. Deciphering the molecular bases of the CMs is required for therapy and illuminates structure-function relationships in these proteins. Here, we analyze the effects of a mutation in 1 of 4 homologous subunits in the AChR from a CM patient, a Leu to Pro mutation at position 42 of the δ subunit. The mutation is located in a region of contact between subunits required for rapid opening of the AChR channel and impedes the rate of channel opening. Substitutions of Gly, Lys, or Asp for δL42, or substitutions of Pro along the local protein chain, also slowed channel opening. Substitution of Pro for Leu in the ε subunit slowed opening, whereas this substitution had no effect in the β subunit and actually sped opening in the α subunit. Analyses of energetic coupling between residues at the subunit interface showed that δL42 is functionally linked to αT127, a key residue in the adjacent α subunit required for rapid channel opening. Thus, δL42 is part of an intersubunit network that enables ACh binding to rapidly open the AChR channel, which may be compromised in patients with CM.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(10)
| Title and authors |
Publication |
Year |
Congenital Myasthenic Syndromes in 2012
Andrew G. Engel
|
Curr Neurol Neurosci Rep
|
2011 |
Current status of the congenital myasthenic syndromes
Andrew G. Engel
|
Neuromuscular Disorders
|
2011 |
What have we learned from the congenital myasthenic syndromes.
Andrew G Engel, Xin-Ming Shen, Duygu Selcen, Steven M Sine
|
J. Mol. Neurosci.
|
2010 |
Altered plasmodial surface anion channel activity and in vitro resistance to permeating antimalarial compounds
Godfrey Lisk, Margaret Pain, Morgan Sellers, Philip A. Gurnev, Ajay D. Pillai, Sergey M. Bezrukov, Sanjay A. Desai
|
Biochimica et Biophysica Acta (BBA) - Biomembranes
|
2010 |
Pin1 regulates parathyroid hormone mRNA stability
Rajiv Kumar
|
J. Clin. Invest.
|
2009 |
The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism
Morris Nechama, Takafumi Uchida, Irit Mor Yosef-Levi, Justin Silver, Tally Naveh-Many
|
J. Clin. Invest.
|
2009 |
The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation.
Zhong-Jian Shen, Stephane Esnault, Anna Schinzel, Christoph Borner, James S Malter
|
Nat Immunol
|
2009 |
Functional and morphological evidence of age-related denervation in rat laryngeal muscles.
Colleen A McMullen, Francisco H Andrade
|
J. Gerontol. A Biol. Sci. Med. Sci.
|
2009 |
Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up
V. Cottin, C. Khouatra, R. Dubost, J -C. Glérant, J -F. Cordier
|
Allergy
|
2009 |
Further Observations in Congenital Myasthenic Syndromes
Andrew G. Engel, Xin-Ming Shen, Duygu Selcen, Steven M. Sine
|
Annals of the New York Academy of Sciences
|
2008 |
|